News tagged ‘Genetics’ clear
- Lung cancer among younger, healthier, and non-smoking individuals "seems to be emerging as its own subtype of lung cancer — one for which new, powerful treatments are needed to make it a livable disease" said Dr. Geoffrey Oxnard, a lung cancer specialist at Dana-Farber Cancer Institute.
Tags: LungCancer, Genetics
- Dr. Katherine Janeway led a study finding some pediatric cancer patients harbor mutations in their tumor or germline that have potential clinical significance, either for diagnosis or treatment.
Tags: ChildhoodCancer, Genomics, Genetics
- Dr. Pasi A. Jänne discusses a new study that demonstrates that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.
Tags: LungCancer, TargetedTherapy, Genetics
- Dr. Judy Garber commented on ways genetic testing is playing a role in cancer treatment and prevention.
Tags: Genetics, Immunotherapy
- Dr. Judy Garber led a study that sought to determine which breast cancer patient populations should be screened for abnormalities and how best to integrate that information into treatment protocols.
Tags: BreastCancer, Genetics
- MolecularMD has obtained patent rights to technology—jointly owned by researchers at Dana-Farber and the Broad Institute. MolecularMD said it is developing diagnostic assays for use in clinical trials exploring the efficacy of targeted therapies.
Tags: BasicResearch, TargetedTherapy, Genetics
- Dr. Ursula Matulonis commented on a study that found women with BRCA-1 mutations can reduce their risk of breast and ovarian cancer if they get their ovaries removed by age 35.
Tags: BreastCancer, OvarianCancer, Genetics